ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NAOV NanoVibronix Inc

0.7384
0.0034 (0.46%)
최종 업데이트: 03:31:40
15분 지연
기업명 주식 심볼 시장 주식 타입
NanoVibronix Inc NAOV 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0034 0.46% 0.7384 03:31:40
개장가 저가 고가 종가 전일 종가
0.723 0.6775 0.7538 0.735
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00BWNanoVibronix Announces PainShield Will Be Included in..
09/04/202421:30BWNanoVibronix Issues Letter to Stockholders
28/03/202421:30BWNanoVibronix Signs Agreement for Research and Development of..
27/02/202407:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202409:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202409:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202409:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202405:45EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/01/202406:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/01/202406:30EDGAR2Form 8-K - Current report
12/12/202306:30EDGAR2Form 8-K - Current report
07/12/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202323:00BWNanoVibronix Featured in Your Bladder Health Magazine
05/12/202310:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202310:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202310:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202310:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:45EDGAR2Form 8-K - Current report
04/12/202323:00BWNanoVibronix Enters into Letter of Intent with APOGEPHA..
28/11/202323:00EDGAR2Form 8-K - Current report
28/11/202323:00BWNanoVibronix Announces Agreement for Clinical Study of..
21/11/202322:30EDGAR2Form 8-K - Current report
21/11/202322:30BWNanoVibronix Regains Nasdaq Compliance
14/11/202322:30BWNanoVibronix Issues Letter to Shareholders
14/11/202306:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:30EDGAR2Form 8-K - Current report
07/11/202322:30BWNanoVibronix UroShield Products Available on NHS Drug Tariff..
27/09/202321:00EDGAR2Form 8-K - Current report
27/09/202321:00BWNanoVibronix Gains Approval for Inclusion of UroShield..
22/09/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
21/09/202323:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/09/202323:25EDGAR2Form RW - Registration Withdrawal Request
13/09/202305:15EDGAR2Form S-3 - Registration statement under Securities Act of..
06/09/202321:30EDGAR2Form 8-K - Current report
06/09/202321:30BWNanoVibronix Announces Presentation of Positive Independent..
02/09/202305:30EDGAR2Form 8-K - Current report
31/08/202303:29BWNanoVibronix Announces $5 Million Private Placement Priced..
30/08/202321:30EDGAR2Form 8-K - Current report
30/08/202321:30BWNanoVibronix Cites Positive Results from Independent Testing..
30/08/202305:05EDGAR2Form 8-K - Current report
30/08/202305:05BWNanoVibronix Responds to CMS’ Determination for PainShield
28/08/202321:30EDGAR2Form 8-K - Current report
28/08/202321:30BWNanoVibronix Applies for Inclusion of UroShield Products in..
24/08/202305:45EDGAR2Form 8-K - Current report
23/08/202321:45BWNanoVibronix Extends Distribution Agreement with Its Largest..
12/08/202306:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202306:14EDGAR2Form S-1/A - General form for registration of securities..
02/08/202305:30EDGAR2Form S-3 - Registration statement under Securities Act of..
21/07/202305:45EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock